4.4 Article

Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy

期刊

EPILEPSY & BEHAVIOR
卷 14, 期 2, 页码 324-329

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yebeh.2008.10.021

关键词

Antiepileptic drugs; Adherence; Costs; Elderly; Claims data

资金

  1. GlaxoSmithKline (GSK)

向作者/读者索取更多资源

Retrospective insurance claims from the United States were analyzed to assess nonadherence to antiepileptic drugs (AEDs) and the association between AED nonadherence, seizures, and health care costs in elderly persons with epilepsy. Inclusion criteria were: age >= 65, epilepsy diagnosis between I January 2000 and 31 June 2006, >= 2 AED prescriptions, and insurance enrollment for >= 6 months pre- and >= 12 months post-AED initiation. Adherence was evaluated using the medication possession ratio (MPR), with MPR < 0.8 defining nonadherence. Per-patient outcomes were evaluated over 12 months post-AED initiation. Of 1278 patients identified, 41% were nonadherent. Seizure, defined by epilepsy-related inpatient or emergency department admission, occurred in 12.1% of nonadherers versus 8.2% of adherers (P = 0.0212). Nonadherers had higher inpatient (+$872, P = 0.001), emergency department (+$143, P = 0.0008), other outpatient ancillary (+$1741, P = 0.0081), and total health care (+$2674, P = 0.0059) costs. AED adherence among elderly patients with epilepsy is suboptimal and associated with increased seizures and health care costs. (C) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据